☆ 4.5 Article

Persistent RNA SARS-CoV-2 Detection in a HIV-Infected Patient

HEALTHCARE (2022)

Related references

Note: Only part of the references are listed.

Editorial Material Medicine, General & Internal

The Goldilocks Time for Remdesivir - Is Any Indication Just Right?

Emily L. Heil et al.

Summary: The world has been grappling with a severe pandemic caused by SARS-CoV-2 for the past two years. Imperfect vaccine uptake and ongoing emergence of variants suggest that SARS-CoV-2 may become endemic, necessitating continued need for early therapies to reduce risk and transmission.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Virology

Persistent SARS-CoV-2 Infection in a Patient With Non-hodgkin Lymphoma: Intra-Host Genomic Diversity Analysis

Angelica Bianco et al.

Summary: In this study, viral genetic analysis was conducted on a diabetic male patient with Non-Hodgkin Lymphoma who had persistent SARS-CoV-2 infection. The analysis revealed the evolution of intra-host variability during the course of the long-lasting infection.

FRONTIERS IN VIROLOGY (2022)

Add to Collection

Article Immunology

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Ji Hoon Baang et al.

Summary: This case illustrates challenges in managing immunocompromised hosts with chronic COVID-19, who may act as persistent shedders and sources of transmission. The patient's lack of seroconversion and prolonged course highlight the importance of humoral immunity in resolving viral infections.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Infectious Diseases

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity Comment

Dafna Yahav et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Infectious Diseases

Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study

Hui Long et al.

Summary: This study described the viral kinetics of symptomatic patients with SARS-CoV-2 infection and found that older age, female gender, and longer interval from symptom onset to admission were associated with prolonged viral shedding. IgM antibody titer was significantly higher in the low viral loads group at 41-60 days after symptom onset. The average viral loads were higher in early outbreak periods compared to late periods at the population level.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Letter Medicine, General & Internal

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

Min-Chul Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient

Marielton dos Passos Cunha et al.

Summary: A study showed that some individuals mildly affected by SARS-CoV-2 infection exhibited atypical durations of viral shedding, with one HIV-positive patient shedding SARS-CoV-2 RNA and sgRNA for 232 and 224 days respectively after onset. These results suggest that some infected patients might shed potentially infectious SARS-CoV-2 virus for longer periods of time.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Influence of multidisciplinary therapeutic approach on fibromyalgia patients

Simona Patru et al.

Summary: The study found that kinetic therapy can significantly reduce symptoms in fibromyalgia patients and improve their quality of life. Combining cognitive-behavioral and occupational therapy interventions may be a key element in completing the complex treatment of fibromyalgia patients.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Add to Collection

Article Immunology

The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study

Chiara Sepulcri et al.

Summary: Immunocompromised patients can have prolonged shedding of SARS-CoV-2 and clinical relapses of COVID-19, with differences in cell immune dynamics and absence of virus-specific antibodies detected.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report

Melissa Niyonkuru et al.

Summary: This case report highlights the importance of considering the immunological status of patients when developing isolation guidelines for those infected with SARS-CoV-2. It also emphasizes the need for immune markers related to viral shedding in immunocompromised patients, as shown by the differences in humoral and cellular immune responses observed in the two cases.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Viable SARS-CoV-2 Shedding

Min-Chul Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19

Sarah C. J. Jorgensen et al.

PHARMACOTHERAPY (2020)

Add to Collection

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Cell Biology

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity

Vineet Agarwal et al.

CELL DEATH DISCOVERY (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.